Previous 10 | Next 10 |
home / stock / gnwsf / gnwsf news
Stagezero Life Sciences ( OTCPK:GNWSF ) : Q2 GAAP EPS of $0.00. More news on: StageZero Life Sciences Ltd., Earnings news and commentary, Healthcare stocks news, , Read more ...
Stagezero Life Sciences ( OTCPK:GNWSF ): Q1 GAAP EPS of -$0.01. More news on: Stagezero Life Sciences Ltd., Earnings news and commentary, Healthcare stocks news, , Read more ...
StageZero Life Sciences (GNWSF) Q4 2019 Earnings Conference Call May 19, 2020 05:00 PM ET Company Participants James Howard-Tripp - Chairman and CEO Conference Call Participants Presentation Operator Ladies and gentlemen, thank you for attending your StageZero Life Scie...
NEW YORK, NY / ACCESSWIRE / March 18, 2020 / StageZero Life Sciences (TSX:SZLS), is spearheading multiple cancer detection screening through their next generation test, Aristotle. StageZero Life Sciences will be presenting at this year's New York City based Investor Summit on March 25 th -26...
Vancouver, British Columbia--(Newsfile Corp. - May 21, 2019) - GeneNews Limited (TSX: GEN), a life sciences company specializing in blood-based biomarker tests for early cancer detection, has launched the company's first awareness campaign on prostate cancer. The awareness program cleverly use...
GeneNews ( OTCPK:GNWSF ): Q1 GAAP EPS of -$0.05. Revenue of $0.05M (+400.0% Y/Y) Press Release More news on: GeneNews Limited, Earnings news and commentary, Healthcare stocks news, ,
GeneNews Limited (GNWSF) Q4 2018 Results Conference Call April 03, 2019 04:30 PM ET Company Participants James Howard-Tripp - Chairman and CEO Conference Call Participants Presentation Operator Good afternoon. And welcome to the GeneNews 2018 Q4 and Year-end Investor Co...
GeneNews ( OTCPK:GNWSF ): Q4 GAAP EPS of -$0.03. More news on: GeneNews Limited, Earnings news and commentary, Healthcare stocks news, , Read more ...
Study demonstrates validity of blood-based biomarker test as an adjunct method to colon cancer screening tests in non-compliant patient populations TORONTO , Jan. 28, 2019 /PRNewswire/ - GeneNews Limited (TSX:GEN) ("GeneNews" or the "Company") today announced it has published a new st...
GeneNews Limited (GNWSF) Q3 2018 Earnings Conference Call November 15, 2018 8:30 AM ET Executives James Howard-Tripp – Chairman and Chief Executive Officer Analysts Georges Lachapelle – Desjardins Securities Jeffrey Stevenson – Private Investor Frank Mi...
News, Short Squeeze, Breakout and More Instantly...
Genenews Ltd New Company Name:
GNWSF Stock Symbol:
OTCMKTS Market:
With Record Turnout Majority of Votes Support Directors TORONTO, ON / ACCESSWIRE / June 30, 2021 / StageZero Life Sciences, Ltd (TSX:SZLS) ("StageZero" or the "Company") is pleased to report that shareholders, voted in favour of the tabled resolutions, including the election of all nomi...
StageZero's Richmond, VA laboratory provides same-day test results and documentation required for travel to many international destinations RICHMOND, VA / ACCESSWIRE / June 2, 2021 / StageZero Life Sciences, Ltd. (TSX:SZLS) ("StageZero" or the "Company"), a specialist in PCR testing d...
TORONTO, ON / ACCESSWIRE / May 5, 2021 / StageZero Life Sciences, Ltd. (TSX:SZLS) ("StageZero" or the "Company"), a specialist in PCR testing dedicated to the early detection of multiple diseases through whole blood, today announced it will distribute via its partner Ichor Blood Services thr...